BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 19, 2008
View Archived Issues
Mechanistic and phase II data on HIV vaccine (PE)HRG214 presented
Read More
HIV-1-specific responses seen with vaccine candidate MVA-B in phase I study
Read More
DNGR-1 receptor allows antigen targeting to dendritic cell subsets and tumor therapy
Read More
Recent patents describe new antiglaucoma agents
Read More
Novel oncolytic agents disclosed in recent patent literature
Read More
Morphotek signs license agreement with NCI for monoclonal antibody for prostate cancer
Read More
Threshold initiates phase I/II clinical trial of TH-302 in solid tumors
Read More
Tekmira and Bristol-Myers enter RNAi research collaboration
Read More
Karo Bio and Wyeth extend atherosclerosis collaboration until August 2009
Read More
Dendreon initiates phase II ProACT trial of Provenge in prostate cancer
Read More
Moberg Derma reports promising results from phase III study of K-301 in seborrheic dermatitis
Read More
Palatin reports results from phase IIa clinical trial of PL-3994 in heart failure
Read More
Pharmaxis completes enrollment in phase III clinical trial of Bronchitol in cystic fibrosis
Read More
A novel FAAH inhibitor effective in inflammatory and neuropathic pain models
Read More
nNOS inhibitors active in neuropathic pain model
Read More
Cytos and Pfizer sign research and license agreement for certain novel vaccines
Read More
DSMB recommends continuation of phase III clinical trial of Bioniche's Urocidin
Read More
Yakult to initiate Japanese preclinical and clinical studies of ThermoDox in liver cancer
Read More
EMEA accepts for review Introgen's MAA for Advexin
Read More
Dyax reports topline results from EDEMA4 phase III clinical trial of DX-88 in HAE
Read More
Access and Milestone signed definitive license agreement for MuGard in North America
Read More
PregLem initiates phase III clinical trial program for PGL-4001 in uterine myoma
Read More